Medical/Pharmaceuticals
Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis (MF)
SHANGHAI and HONG KONG, July 6, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-07-06 08:00
4967
South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology
DAEJEON, South Korea and CASTRES, France, July 6, 2021 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have entered into a license agreement granting worldwide exclusive rights toPierre Fabre to develop and commercialize a family of hum...
2021-07-06 07:00
5640
SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting
TIANJIN, China, July 5, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, today announced that they have teamed up with the National University of Ireland Galway (NUI Galway) to conduct a clinical trial for a new assessment method for stenting. The trial will employ the...
2021-07-05 19:42
3466
Octapharma's ongoing dedication to improving the lives of people with haemophilia and von Willebrand disease to be showcased at the ISTH 2021 Congress
LACHEN, Switzerland, July 5, 2021 /PRNewswire/ -- Octapharma announced today that new clinical and scientific findings encompassing their Haematology portfolio, including Nuwiq®, wilate®, octanate® and octanine®F, will be presented at the upcoming International Society on Thrombosis and Haemostas...
2021-07-05 19:30
3422
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories
SHANGHAI, July 5, 2021 /PRNewswire/ -- Everest Medicines
2021-07-05 18:16
5169
Tianjin Haihe Media Group presents an extraordinary story of a TCM doctor and his battle against COVID-19 in China
TIANJIN, China, July 3, 2021 /PRNewswire/ -- Zhang Boli, director of the Tianjin University of Traditional Chinese Medicine inChina, was awarded with the national honorary title "the People's Hero" by the Chinese central government for his outstanding contribution to the country's fight against t...
2021-07-05 09:14
4919
Abbisko and Sperogenix Announce An Exclusive Agreement to Develop ABSK021 for ALS and Other Rare Neurological Diseases in Greater China
SHANGHAI, BEIJING, HONG KONG, July 5, 2021 /PRNewswire/ -- Sperogenix (Shanghai ) MedTech Co., Ltd. ("Sperogenix"), a subsidiary of Sperogenix Therapeutics (platform company for development and commercialization of rare diseases medications inChina), has entered into an exclusive licensing agreeme...
2021-07-05 08:51
2425
Arctic Vision Joins Forces with the University of Hong Kong Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease
SHANGHAI and HONG KONG, July 4, 2021 /PRNewswire/ -- Arctic Vision, a China -based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today a new research collaboration with Prof.Christopher Leung, Head and Clinical Professor at the ...
2021-07-05 08:00
2023
Transcenta Provides Program Update for Anti-Claudin18.2 Monoclonal Antibody TST001 and Reports Promising Early Anti-Tumor Responses in Patients with Gastric Cancer
SUZHOU, China, July 2, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announces that promising anti-tumor response...
2021-07-02 21:02
3175
Ramesh Subrahmanian joins Everlife Board
SINGAPORE and MUMBAI, India, July 2, 2021 /PRNewswire/ -- Everlife Holdings
Pte. Ltd. ("Everlife"), a leading manufacturer and distributor of medical
devices and laboratory equipment and consumables inAsia, has appointed Ramesh
Subrahmanian to the company's Board of Directors.
2021-07-02 15:58
4928
New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro (GL-LIS), and Glargine (GL-GLA) Presented at the American Diabetes Association's 81st Scientific Sessions
BEIJING and BRIDGEWATER, NJ., July 2, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), announced positive Phase 1 clinical trial results at the 81st Scientific Sessions of the American Diabetes Association (ADA),June 25th – 29...
2021-07-02 15:00
3728
SonoScape obtains CE Mark for its linear array echoendoscope EG-UC5T
SHENZHEN, China, July 2, 2021 /PRNewswire/ -- On April 30th, SonoScape received the CE-marking, the product's "Passport toEurope", for its linear-array echoendoscope EG-UC5T. This further expands SonoScape's endoscopic ultrasound (EUS) portfolio in the international market. Reaping the benefits o...
2021-07-02 14:33
5121
Nippon Express (China) Signs Memorandum on Pharmaceutical Logistics Business Collaboration with Shanghai Shengsheng Logistics
TOKYO, July 2, 2021 /PRNewswire/ -- - Move Aimed at Enhancing Pharmaceutical Logistics Efforts - Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a local subsidiary of Nippon Express Co., Ltd., concluded a memorandum on business collaboration with Shanghai Shengsheng Logistics Co., Lt...
2021-07-02 14:00
3058
China's Leading Health Insurance Platform QingSong Health Group and the World's Largest Insurance Company AXA Reached a Strategic Cooperation
BEIJING, July 2, 2021 /PRNewswire/ -- On June 25th, China's leading health insurance technology platform QingSong Health Group and AXA Insurance Group reached a strategic cooperation. The two parties will work together in in-depth exploration of insurance education, insurance innovation, health s...
2021-07-02 13:48
4233
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70
STOCKHOLM, Sweden, July 2, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that it has signed a licence agreement under which Lipidor grants RELIFE S.r.l., part of leading international pharmaceutical company, Menarini Group, exclusive rights to re...
2021-07-02 05:32
2476
First Naturally-designed and Personalised Bioprosthesis SingValve Set to Revolutionise Heart Valve Surgery
SINGAPORE, July 1, 2021 /PRNewswire/ -- A naturally-designed human-like personalised heart valve bioprosthesis developed by a team of clinician-scientists from theNational University Health System (NUHS) looks set to be a game changer in the next generation of "personalised medicine" and further...
2021-07-01 21:00
3376
Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology
SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- Korea National Institute of
Health (KNIH), Korea's top research center in the field of hygiene and medicine
(with Mr. Kwon Jun-Wook as President) conducted a field inspection of key
companies with mRNA technology.
2021-07-01 21:00
2567
Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany
SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- A Phase 1 study on new drug candidate IDG16177 of novel oral treatment for type 2 diabetes, which is being developed by Ildong Pharmaceutical, is initiated inGermany. On June 28th (local time), Ildong Pharmaceutical obtained approval for the Phas...
2021-07-01 21:00
2663
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
* First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors * China sites to join the dose expansion part of the study to accelerate TJ- CD4B/ABL111 development * Results of TJ-L14B/ABL503 preclinical studies accepted for publica...
2021-07-01 20:00
13693
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's
MELBOURNE, Australia and SAN FRANCISCO, July 1, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the United States Patent and Trademark Office (USPTO). The patent secures a ...
2021-07-01 19:50
14060
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 280 media titles]
2026-05-20 09:15Most Read
PT Telkom Indonesia (Persero) Tbk 2025 Annual Report on Form 20-F
2026-05-16 00:26
7986
Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease
2026-05-16 11:14
6013
Lepro Introduces STV1, a TV Backlight That Combines Screen Sync, AI Lighting, and Easier Setup
2026-05-16 00:00
5785
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
5493
